To investigate the specific role of DNASE1L3 in the treatment of HCC, we overexpressed DNASE1L3 (LV-D) in two HCC cell lines with low expression levels, namely MHCC97-H and PLC/PRF/5. The gene discussed is DNASE1L3; the disease is hepatocellular carcinoma.